| Financial Year |
March 31 2023 |
| Monetary Funds |
2,587,060,152.04 |
| Held-for-trading Financial Assets |
272,017,758.49 |
| Notes Receivable |
1,316,055,598.25 |
| Accounts Receivable |
4,342,415,890.66 |
| Advances to Suppliers |
457,707,804.48 |
| Other Receivables |
203,936,476.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,612,732,808.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,231,205.10 |
| Other Current Assets |
186,576,490.59 |
| Total Current Assets |
14,431,077,444.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,868,490.09 |
| Long-term Equity Investment |
243,789,149.48 |
| Investment Properties |
11,387,145.06 |
| Fixed Assetes |
4,115,754,190.35 |
| Under-construction Projects |
560,572,411.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
659,471,593.07 |
| R&D expenses |
66,548,594.06 |
| Goodwill |
555,320,233.97 |
| Long-Term Deferred and Prepaid Expenses |
116,493,011.23 |
| Deferred Income Tax Assets |
154,923,756.46 |
| Other Non-Current Assets |
117,718,338.24 |
| Sub-Total of Non-Current Assets |
6,722,342,481.85 |
| Total Assets |
21,153,419,926.03 |
| Short-Term Loans |
1,215,252,787.85 |
| Trading Financial liabilities |
503,495.57 |
| Notes Payable |
3,658,266,456.34 |
| Accounts Payable |
4,167,642,381.26 |
| Accounts Received In Advance |
4,547,267.60 |
| Employee Compensation Payable |
236,580,384.62 |
| Taxes Payable |
100,159,858.32 |
| Interest Payable |
31,274,643.43 |
| Dividend Payable |
2,183,594.71 |
| Other payables |
509,906,056.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
539,022,043.81 |
| Other Current Liabilities |
59,417,624.76 |
| Sub-Total of Current Liabilities |
10,575,143,404.75 |
| Long-term Loans |
1,780,055,407.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
97,520,224.82 |
| Deferred Income Tax Liabilities |
44,527,724.83 |
| Other Non-Current Liabilities |
1,249,576,912.99 |
| Sub-Total of Non-Current Liabilities |
3,249,890,693.25 |
| Total Liabilities |
13,825,034,098.00 |
| Paid-In Capital(Or Share Stock) |
1,083,279,406.00 |
| Capital Surplus |
3,557,093,656.37 |
| Surplus Reserve |
366,716,110.75 |
| LESS:Treasury Stock |
45,601,650.00 |
| Undistributed Profits |
1,196,645,049.86 |
| Minority Stockholder's Interest |
1,254,715,148.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,073,670,679.16 |
| Owner's Equity（Stockholder's Equity） |
7,328,385,828.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,153,419,926.03 |
